1Secher NH,Van Lieshout JJ.Hypovolaemic shock and pain[J].Exp Physiol,2009,94(6):641-647.
2Bremander A,Bergman S,Arvidsson B.Perception of multimodal cognitive treatment for people with chronic widespread pain-changing one's life plan[J].Disabil Rehabil,2009,21:1-9.
4De la O-Arciniega M,Díaz-Reval MI,Cortés-Arroyo AR,et al.Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury[J].Pharmacol Biochem Behav,2009,92(3):457-464.
5Ho KY,Jones L,Gan TJ.The effect of cultural background on the usage of complementary and alternative medicine for chronic pain management[J].Pain Physician,2009,12(3):685-688.
6Nichols DE,Frescas SP,Chemel BR,et al.High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO):a high-affinity 5-HT2A receptor-selective agonist radioligand[J].Bioorg Med Chem,2008,16(11):6116-6123.
7Jain KK.Gene therapy for pain.Expert[J].Opin Biol Ther,2008,8(12):1855-1866.
8Glorioso JC,Fink DJ.Herpes vector-mediated gene transfer in the treatment of chronic pain[J].Mol Ther,2009,17(1):13-18.
10Mata M,Hao S,Fink DJ.Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha[J].Neurosci Lett,2008,437(3):209-213.
